Taysha Gene Therapies, Inc. Common Stock Share Price
NASDAQ: TSHAHealthcare
Live Taysha Gene Therapies, Inc. Common Stock Share Price Chart
O H L
Taysha Gene Therapies, Inc. Common Stock Performance Overview
Days Range
▼
$5.01Low
$5.19High
Markets Today
| Previous Close | $5.16 |
|---|---|
| Open | $5.15 |
| Volume | 1,879,299 |
| Day's Range | $5.01 - $5.19 |
| 52W Range | $2.71 - $7.30 |
| Market Cap | $1.65 B |
Historical Performance
| 1M Returns | -16.64 |
|---|---|
| 3M Returns | -19.63 |
| 6M Returns | +15.96 |
| 1Y Returns | +72.58 |
| 5Y Returns | -74.07 |
| 10Y Returns | NA |
Taysha Gene Therapies, Inc. Common Stock Fundamentals
| Market Cap | $1.65 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $9.77 M |
| ROE TTM | -0.68 |
| EPS TTM | $-0.41 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.26 |
| EBITDA | $-109.35 M |
| Profit Margin | -1115.27 |
| Market Cap | $1.65 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $9.77 M |
| ROE TTM | -0.68 |
| EPS TTM | $-0.41 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.26 |
| EBITDA | $-109.35 M |
| Profit Margin | -1115.27 |
Taysha Gene Therapies, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $2.30 M | $1.99 M | $0 | $5.49 M | $0 | $0 |
| Gross Profit + | $2.30 M | $1.99 M | $0 | $5.49 M | $0 | $0 |
| Operating Income | -$21.42 M | -$26.75 M | -$34.02 M | -$28.30 M | -$43.49 M | -$47.35 M |
| EBITDA | -$21.14 M | -$26.48 M | -$33.74 M | -$28.00 M | -$43.19 M | -$50.49 M |
| Interest Expense | -$19.00 K | -$17.00 K | -$15.00 K | -$12.00 K | -$9.00 K | -$6.00 K |
| Depreciation | $283.00 K | $277.00 K | $286.00 K | $299.00 K | $295.00 K | -$3.14 M |
| Income Before Tax | -$21.53 M | -$26.88 M | -$32.73 M | -$27.85 M | -$42.41 M | -$46.64 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$21.53 M | -$26.88 M | -$32.73 M | -$27.85 M | -$42.41 M | -$46.64 M |
| Net Profit Margin | -935.23% | -1353.58% | - | -507.77% | - | - |
Taysha Gene Therapies, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.00 K | $3.00 K | $3.00 K | $3.00 K | $3.00 K | $3.00 K |
| Reserve & Surplus | -$626.12 M | -$651.41 M | -$684.59 M | -$711.49 M | -$752.73 M | -$799.58 M |
| Non-Current Liabilities | $60.75 M | $59.26 M | $68.93 M | $69.83 M | $68.31 M | $57.19 M |
| Current Liabilities | $22.56 M | $25.35 M | $28.63 M | $26.55 M | $20.10 M | $25.98 M |
| Total Liabilities | $83.30 M | $84.60 M | $97.56 M | $96.38 M | $88.41 M | $83.17 M |
| Fixed Assets | $7.24 M | $6.96 M | $6.80 M | $6.74 M | $6.45 M | $2.41 M |
| Current Assets | $120.71 M | $316.26 M | $299.95 M | $324.65 M | $282.25 M | $461.43 M |
| Total Assets | $138.36 M | $333.33 M | $316.55 M | $343.32 M | $300.35 M | $470.43 M |
Taysha Gene Therapies, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$21.53 M | -$26.88 M | -$32.73 M | -$27.85 M | -$42.41 M | -$46.64 M |
| Operating Cash Flow | -$22.02 M | -$20.18 M | -$24.17 M | -$26.72 M | -$40.88 M | -$40.42 M |
| Investing Cash Flow | -$371.00 K | $62.00 K | -$48.00 K | -$247.00 K | -$3.02 M | $1.00 K |
| Financing Cash Flow | -$52.00 K | $216.29 M | $8.80 M | $49.56 M | $711.00 K | $216.66 M |
| Change in Cash | -$22.44 M | $196.17 M | -$15.42 M | $22.59 M | -$43.19 M | $176.23 M |
Taysha Gene Therapies, Inc. Common Stock Return Calculator
The Taysha Gene Therapies, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,543
Invested Amount$10,000
Est. Returns$-7,457
About Taysha Gene Therapies, Inc. Common Stock
Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.
Popular Stocks
FAQs
What is the share price of Taysha Gene Therapies, Inc. Common Stock today?
Taysha Gene Therapies, Inc. Common Stock (TSHA) share price as of September 18, 2026 is $5.06. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Taysha Gene Therapies, Inc. Common Stock?
Yes, Indian Investors can invest in the Taysha Gene Therapies, Inc. Common Stock (TSHA) Share by opening an international trading account with Angel One.
How can I purchase Taysha Gene Therapies, Inc. Common Stock shares in India?
Purchasing Taysha Gene Therapies, Inc. Common Stock (TSHA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Taysha Gene Therapies, Inc. Common Stock (TSHA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Taysha Gene Therapies, Inc. Common Stock?
Yes, you can purchase fractional shares of Taysha Gene Therapies, Inc. Common Stock (TSHA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Taysha Gene Therapies, Inc. Common Stock?
The market capitalization of Taysha Gene Therapies, Inc. Common Stock on September 18, 2026, is $1.65 B.
In which sector Taysha Gene Therapies, Inc. Common Stock belongs?
Taysha Gene Therapies, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Taysha Gene Therapies, Inc. Common Stock stocks?
In order to invest in Taysha Gene Therapies, Inc. Common Stock (TSHA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
